Table 2.
Bivariate associations of patient factors with completion of guideline-recommended postpartum screening among women with gestational diabetes mellitus (GDM): the Gestational Diabetes’ Effects on Moms (GEM) study (N=1642)
| Screened (n=857) |
Unscreened (n=785) |
P value | |
| Racial/ethnic background | <0.0001 | ||
| Black | 21 (2.5) | 40 (5.1) | |
| Chinese American | 128 (14.9) | 47 (6.0) | |
| Filipina | 100 (11.7) | 81 (10.3) | |
| South Asian | 86 (10.0) | 65 (8.3) | |
| Asian, other | 95 (11.1) | 69 (8.8) | |
| Latina | 161 (18.8) | 180 (22.9) | |
| Non-Hispanic White | 198 (23.1) | 196 (25.0) | |
| Multiracial/other | 68 (7.9) | 136 (13.6) | |
| Education: less than a 4-year college degree | 347 (40.5) | 469 (59.7) | <0.0001 |
| Parity | <0.0001 | ||
| 0 | 496 (46.9) | 296 (37.7) | |
| 1 | 362 (34.2) | 264 (33.6) | |
| ≥2 | 193 (18.2) | 225 (28.7) | |
| Elevated T2D risk | 121 (14.1) | 176 (22.4) | <0.0001 |
| Perinatal depression | 175 (20.4) | 232 (29.6) | <0.0001 |
| Attended postpartum visit | 846 (98.7) | 691 (88.0) | <0.0001 |
| Preterm delivery | 84 (9.8) | 98 (12.5) | 0.08 |
| Cesarean delivery | 286 (33.4) | 261 (33.2) | 0.96 |
| Use of GDM medication | 223 (26.0) | 234 (29.8) | 0.09 |
| GEM trial arm | 0.08 | ||
| Usual care | 455 (53.1) | 383 (48.8) | |
| Intervention | 402 (46.9) | 402 (51.2) |
Values are presented as frequencies (%).
Screening was defined as a 2-hour, 75-g oral glucose tolerance test within 4–12 weeks postpartum.
P values are results from Pearson’s χ2 tests comparing those screened versus unscreened.
T2D, type 2 diabetes.